Entegris Other Income (Expense) increased by 65.9% to -$1.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from -$1.30M to -$1.40M. Over 2 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -45.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$23.56M | -$1.92M | -$1.89M | -$4.90M | -$9.62M | -$12.85M | $4.66M | -$7.72M | -$10.24M | -$12.09M | -$14.30M | -$3.00M | $200.00K | -$1.30M | $200.00K | -$4.20M | -$4.10M | -$1.40M |
| QoQ Change | — | +91.9% | +1.5% | -159.6% | -96.2% | -33.6% | +136.2% | -265.8% | -32.6% | -18.0% | -18.3% | +79.0% | +106.7% | -750.0% | +115.4% | <-999% | +2.4% | +65.9% |
| YoY Change | — | — | — | — | +59.2% | -570.4% | +195.0% | +19.7% | +20.3% | — | -407.0% | +61.2% | +102.0% | +90.9% | +106.7% | <-999% | — | -7.7% |